Chapter 1. INFLUENZA DIAGNOSTICS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. INFLUENZA DIAGNOSTICS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. INFLUENZA DIAGNOSTICS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. INFLUENZA DIAGNOSTICS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. INFLUENZA DIAGNOSTICS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. INFLUENZA DIAGNOSTICS MARKET– By Test Type

6.1. Molecular Diagnostic Assay:

       6.1.1. Loop-mediated Isothermal Amplification-based Assay (LAMP)

       6.1.2. Nucleic Acid Sequence-based Amplification (NASBA) Test

       6.1.3. Other Molecular Diagnostic Assays

       6.1.4. RT-PCR

       6.1.5. Simple Amplification-based Assay (SAMBA)

6.2. Traditional Diagnostic Test:

       6.2.1. Rapid Influenza Diagnostic Test (RIDT)

       6.2.2. Viral Culture

       6.2.3. Direct Fluorescent Antibody (DFA) Test

       6.2.4. Serological Assay

Chapter 7. INFLUENZA DIAGNOSTICS MARKET– By End User

7.1. Laboratories

7.2. Hospital

7.3. Other

Chapter 8. INFLUENZA DIAGNOSTICS MARKET– By Region

8.1. North America

8.2. Europe

8.3. The Asia Pacific

8.4. Latin America

8.5. Middle-East and Africa

Chapter 9. INFLUENZA DIAGNOSTICS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

9.1. Company 1

9.2. Company 2

9.3. Company 3

9.4. Company 4

9.5. Company 5

9.6. Company 6

9.7. Company 7

9.8. Company 8

9.9. Company 9

9.10. Company 10

Download Sample